Month: <span>March 2017</span>

Home / 2017 / March
Post

Oral delivery system could make vaccination needle-free

The MucoJet technology is designed to be self-administered. Patients could one day self-administer vaccines using a needleless, pill-sized technology that jet-releases a stream of vaccine inside the mouth, according to a proof-of-concept study conducted at UC Berkeley. The study did not test vaccine delivery in people, but demonstrated that the technology, called MucoJet, is capable...

Post

Prostate therapy without surgery: Thousands of men to benefit from new technique that uses plastic beads to block blood supply and shrink the enlarged gland

Successful trial in Portugal being followed up in UK with results due this year If it is successful the technique could be rolled out for routine use on the NHS  Researchers expect it to largely replace surgery as the standard treatment Tens of thousands of men could benefit from a breakthrough prostate treatment announced today....

Post

Researchers Have Found a “Reset Button” for Aging Cells

IN BRIEF Induced pluripotent stem (iPS) cells may be the key to reversing aging in hematopoietic stem cells. The technique is also particularly useful for combating blood-related cancers and other disorders. FIGHTING DISEASE BEFORE IT STRIKES From revitalizing heartbeats and increasing longevity, to removing disorders via gene editing, blood-borne challenges are approached with new solutions as quickly as we can innovate them....

Post

Virtual Reality Job Interview Training for Veterans with Post Traumatic Stress Disorder

Abstract BACKGROUND Veterans with posttraumatic stress disorder (PTSD) have low employment rates and the job interview presents a critical barrier for them to obtain competitive employment. OBJECTIVE To evaluate the acceptability and efficacy of virtual reality job interview training (VR-JIT) among veterans with PTSD via a small randomized controlled trial (n=23 VR-JIT trainees, n=10 waitlist...

Post

Heart drug improves or stabilizes heart function in Duchenne muscular dystrophy

Human heart.    Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children’s Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease. The results of their study are published...

Post

Biosimilar of costly inflammatory bowel disease therapy found safe and effective

Treatment of Crohn’s disease and ulcerative colitis has been greatly improved by the introduction of biologic therapies such as infliximab (which targets tumour necrosis factor alpha), but at considerable cost. A recent analysis of results from 11 published studies including 829 patients shows that a new and lower-cost biosimilar for infliximab—called CT-P13 (Remsima/Inflectra)—has excellent clinical...

Post

Protein HMGB1 may be the key to better asthma treatment

A new study, published in the Journal of Allergy and Clinical Immunology, investigates a potential new approach to designing drugs for the treatment of asthma. Better interventions could be on the horizon. With asthma cases on the rise, research looking at novel drug targets is more important than ever. Asthma causes an individual’s airways to become inflamed...

Post

Autoimmune disease: Could modified red blood cells lead to new treatments?

New treatments that prevent and alleviate autoimmune diseases may come from using red blood cells to carry disease-specific proteins that retrain the immune system. So concludes a study that shows such an approach works in mice with multiple sclerosis and type 1 diabetes. The researchers say that their method of using red blood cells to...